Search
Patexia Research
Case number 2:21-cv-15392

BIOMARIN PHARMACEUTICAL INC. et al v. TEVA PHARMACEUTICALS, INC. > Documents

Date Field Doc. No.Description (Pages)
Dec 22, 2021 10 Order of Dismissal (2)
Docket Text: ORDER re [9] Notice of Dismissal Without Prejudice. The Clerk of Court shall mark this Matter CLOSED. Signed by Judge Esther Salas on 12/22/2021. (wh)
Dec 21, 2021 9 Notice (Other) (2)
Docket Text: NOTICE by BIOMARIN PHARMACEUTICAL INC., MERCK & CIE Notice of Dismissal Without Prejudice (LIZZA, CHARLES)
Nov 5, 2021 8 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE Returned Executed by BIOMARIN PHARMACEUTICAL INC., MERCK & CIE. TEVA PHARMACEUTICALS, INC. waiver sent on 11/5/2021, answer due 1/4/2022. (LIZZA, CHARLES)
Sep 9, 2021 6 Summons Issued (2)
Docket Text: SUMMONS ISSUED as to TEVA PHARMACEUTICALS, INC. f/k/a TEVA PHARMACEUTICALS DEVELOPMENT, INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (sm)
Sep 9, 2021 7 AO120 Patent/Trademark Form (1)
Docket Text: AO120 Patent/Trademark Form filed. (sm)
Aug 17, 2021 4 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by WILLIAM C. BATON on behalf of BIOMARIN PHARMACEUTICAL INC., MERCK & CIE (BATON, WILLIAM)
Aug 17, 2021 5 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by SARAH ANN SULLIVAN on behalf of BIOMARIN PHARMACEUTICAL INC., MERCK & CIE (SULLIVAN, SARAH)
Aug 16, 2021 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Magistrate Judge Cathy L. Waldor. (ak, )
Aug 16, 2021 1 Main Document (21)
Docket Text: COMPLAINT against TEVA PHARMACEUTICALS, INC. f/k/a TEVA PHARMACEUTICALS DEVELOPMENT, INC. ( Filing and Admin fee $ 402 receipt number ANJDC-12721619), filed by BIOMARIN PHARMACEUTICAL INC., MERCK & CIE. (Attachments: # (1) Exhibits A-E, # (2) Exhibits F-I, # (3) Civil Cover Sheet)(LIZZA, CHARLES)
Aug 16, 2021 1 Exhibits A-E (208)
Aug 16, 2021 1 Exhibits F-I (220)
Aug 16, 2021 1 Civil Cover Sheet (1)
Aug 16, 2021 2 Corporate Disclosure Statement (aty) (2)
Docket Text: Corporate Disclosure Statement by BIOMARIN PHARMACEUTICAL INC.. (LIZZA, CHARLES)
Aug 16, 2021 3 Corporate Disclosure Statement (aty) (2)
Docket Text: Corporate Disclosure Statement by MERCK & CIE. (LIZZA, CHARLES)
Aug 16, 2021 1 Complaint* (1)
Menu